Anhui Anke BioTech Group

SHE:300009 China Biotechnology

Market Cap

$2.20 Billion

CN¥16.14 Billion CNY

Market Cap Rank

#6161 Global

#916 in China

Share Price

CN¥9.66

Change (1 day)

-0.31%

52-Week Range

CN¥7.59 - CN¥12.30

All Time High

CN¥127.71

Anhui Anke BioTech Group - Asset Resilience Ratio

Latest as of September 2025: 24.77%

Anhui Anke BioTech Group (300009) has an Asset Resilience Ratio of 24.77% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥1.26 Billion

Cash + Short-term Investments

Total Assets

CN¥5.10 Billion

All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2024)

This chart shows how Anhui Anke BioTech Group's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Anhui Anke BioTech Group's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.26 Billion	24.77%
Total Liquid Assets	CN¥1.26 Billion	24.77%

Asset Resilience Insights

Good Liquidity Position: Anhui Anke BioTech Group maintains a healthy 24.77% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.